FOLD
Amicus Therapeutics Inc
NASDAQ: FOLD · HEALTHCARE · BIOTECHNOLOGY
$14.49
+0.00% today
Updated 2026-04-27
Market cap
$4.55B
P/E ratio
—
P/S ratio
7.17x
EPS (TTM)
$-0.09
Dividend yield
—
52W range
$6 – $15
Volume
3.5M
Amicus Therapeutics Inc (FOLD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-4.28%
Operating margin
8.61%
ROE
-11.60%
ROA
2.49%
Debt/equity
1.61x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-46.34M | — | — | — |
| 2007 | $1.78M | $-41.17M | 100.00% | -2,567.54% | -2,307.57% |
| 2008 | $14.97M | $-39.35M | 100.00% | -293.69% | -262.95% |
| 2009 | $64.36M | $-6.57M | 100.00% | -11.42% | -10.20% |
| 2010 | $922000.00 | $-54.94M | 100.00% | -6,056.18% | -5,958.35% |
| 2011 | $21.43M | $-44.41M | 100.00% | -237.41% | -207.20% |
| 2012 | $18.41M | $-48.78M | -10.68% | -287.50% | -264.98% |
| 2013 | $363000.00 | $-59.63M | -3,616.80% | -17,680.72% | -16,427.82% |
| 2014 | $1.22M | $-68.93M | 100.00% | -5,612.83% | -5,631.21% |
| 2015 | $0.00 | $-132.12M | — | — | — |
| 2016 | $4.96M | $-200.04M | 83.20% | -3,668.62% | -4,034.73% |
| 2017 | $36.93M | $-284.00M | 83.11% | -1,196.82% | -769.03% |
| 2018 | $91.25M | $-349.00M | 84.21% | -360.32% | -382.48% |
| 2019 | $182.24M | $-356.39M | 87.95% | -166.84% | -195.56% |
| 2020 | $260.89M | $-276.85M | 88.10% | -94.68% | -106.12% |
| 2021 | $305.51M | $-250.46M | 88.72% | -67.57% | -81.98% |
| 2022 | $329.23M | $-236.57M | 88.28% | -64.43% | -71.85% |
| 2023 | $399.36M | $-151.58M | 90.65% | -19.33% | -37.96% |
| 2024 | $528.29M | $-56.11M | 89.98% | 4.71% | -10.62% |
| 2025 | $634.21M | $-27.11M | 87.32% | 5.44% | -4.27% |